NEW YORK CITY (dpa-AFX) - While reporting financial results for the first
quarter, drug major Pfizer Inc. (PFE) raised its adjusted earnings guidance for
the full-year 2024, while maintaining annual revenue outlook.

For fiscal 2024, the company now projects adjusted earnings in a range of $2.15
to $2.35 per share, up from the prior guidance range of $2.05 and $2.25 per
share.

However, the company continues to project revenues between $58.5 billion and
$61.5 billion, with revenues of about $5 billion for Comirnaty, about $3 billion
for Paxlovid and about $3.1 billion from legacy Seagen.

On average, 23 analysts polled by Thomson Reuters expect the company to report
earnings of $2.21 per share on revenues of $60.02 billion for the year.
Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit
rttnews.com



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX